statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Elevai Labs reports Q4 revenue $698,591 vs. $554,654 in Q3

Elevai Labs reports Q4 results

Company reports record annual revenues of $1.71 Million for 2023, up 123.5% over the previous year Company reports record Q4 2023 revenues of $698,591, up 403% from Q4 2022 NEWPORT BEACH, Calif...

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results

In this piece, we will take a look at the 15 best beauty stocks to invest in. If you want to skip our overview of the global beauty industry, then you can take a look at the 5 Best Beauty Stocks To...

15 Best Beauty Stocks To Invest In

ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers
 Purchase and Provider Journey

 Elevai e-commerce portal webview of the shopping cart and physician finder tool...

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market

ELEVAI LABS announces issuance of patent...

ELEVAI LABS announces issuance of patent

Elevai Labs announces issuance of patent from USPTO

Utility Patent Covers the formulation for ELEVAI's flagship exosome-based skin care productsNEWPORT BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical...

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

NEWPORT BEACH, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, today announced certain...

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

ELEVAI Labs to commercialize use of proprietary technology designed to produce high-quality, cGMP grade mesenchymal stromal cells at lower-costNEWPORT BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE...

Volume	958,494.00
52-Wk High	$4.24
52-Wk Low	$0.5709

ELAB Elevai Labs Inc.

About

Feed

News

Fundamentals